App-Quantinova.ai

L. Baumann Kreuziger - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Cancer Associated Thrombosis and Direct Oral Anticoagulants: A Meta‐analysis of Randomised Clinical Trials

R. Alikhan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Efficacy Outcomes and Treatment Pattern in Patients with Cancer‐associated Venous Thromboembolism: A Korean Nationwide Venous Thromboembolism Study

H.-G. Hwang - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Risk and Management of Cancer‐associated Venous Thromboembolism: A 10‐year Retrospective Study in a Tertiary Teaching Hospital in Hong Kong

C.K.M. Cheung - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Use of Low Molecular Weight Heparin during the Postoperative Period: Perioperative Management Plan of Patients Treated with Direct Oral Anticoagulants

D. Campoy - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Carvedilol

Abnormal ADAMTS13 and Chemotherapy‐associated Thrombosis in Women with Ovarian Cancer

A. Vorobev - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

Comprehensive VTE Prevention Strategy Including Root Cause Analysis of Hospital‐associated Thrombosis Significantly Reduces Potentially Preventable Events: A Single Centre Experience

L.N. Roberts - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Benefit‐risk Assessment of 10mg Daily Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

G.E. Raskob - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

rivaroxaban

Incidence of Venous Thromboembolic Disease in Hospitalized Patients at the “Hospital de Clínicas”, Montevideo ‐ Uruguay

M. Boada - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Prophylaxis for Hospital Acquired Venous Thromboembolism: Why VTE Could Not Be Prevented

F. Fagan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Improving VTE Prevention in the Hospital: Success of Online CME

J. Spyropoulos - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

The Anti‐factor XIa Antibody BAY 1213790 Shows Dose‐dependent Antithrombotic Efficacy without an Increased Risk of Bleeding on Top of Antiplatelet Treatment in Rabbits

A. Buchmueller - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

BAY-1213790

Racial Differences of Protein S Tokushima and Two Protein C Variants as Genetic Risk Factors for Venous Thromboembolism

H. Tsuda - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Protein C

Burden of Hospital Readmissions for Venous Thromboembolism among Patients Hospitalized for Non‐cancer Acute Medical Illness in the US

A. Amin - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Variation of Homocysteinemia during Venous Thrombosis: about 1045 Cases of Thrombosis

F. Sad - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Epidemiological Characteristics of Thromboembolism Related to Oral Contraceptives in Japan: Results of a National Survey

K. Sugiura - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Methadone hydrochloride

Real‐life Safety and Efficiency of Ruling Out venous Thromboembolism in Primary Care Using Clinical Prediction Rules

R. van Maanen - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

The Risk of Venous Thromboembolism Attributed to Recognized Prothrombotic Genotypes

L.H. Evensen - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Beta Thalassaemia Trait is a Likely Reason for the Association Between Red Cell Distribution Width and Venous Thromboembolism‐ a preliminary report

T. Kotila - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

The Risk of Venous Thrombosis Associated with Elevated Coagulation Factor Levels in the Elderly

H. Wang - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Filters

7277 Abstracts